Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation

(2016) Myles Wolf et al.   TRANSPLANTATION

How Well Does Renal Transplantation Cure Hyperparathyroidism?

(2015) Irene Lou et al.   ANNALS OF SURGERY

Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities

(2015) Takashi Hirukawa et al.   Clinical and Experimental Nephrology

Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism

(2015) Hege Pihlstrøm et al.   TRANSPLANTATION

Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function

(2014) Inger H. Bleskestad et al.   CLINICAL TRANSPLANTATION

Abnormal Mineral Metabolism and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: Evidence From Marginal Structural Models Used to Adjust for Time-Dependent Confounding

(2013) Masafumi Fukagawa et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Association of Calcium, Phosphate and Parathyroid Hormone with Renal Allograft Function: A Retrospective Cohort Study

(2013) Thomas F. Hiemstra et al.   AMERICAN JOURNAL OF NEPHROLOGY

Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation

(2013) L. C. Baia et al.   Clinical Journal of the American Society of Nephrology

Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients

(2013) Kamonwan Chartsrisak et al.   BMC Nephrology

Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation

(2012) Kodo Tomida et al.   BONE

Mineral Metabolites and CKD Progression in African Americans

(2012) J. J. Scialla et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renal Phosphate Loss in Long-Term Kidney Transplantation

(2011) S. Sirilak et al.   Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction

(2011) A. Bellasi et al.   Clinical Journal of the American Society of Nephrology

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality

(2011) M. Wolf et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations

(2011) K. Praditpornsilpa et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Natural History of Mineral and Bone Disorders After Living-Donor Kidney Transplantation: A One-Year Prospective Observational Study

(2011) Hiroo Kawarazaki et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Fibroblast Growth Factor-23 in Early Chronic Kidney Disease: Additional Support in Favor of a Phosphate-Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism

(2010) P. Evenepoel et al.   Clinical Journal of the American Society of Nephrology

Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation

(2010) Jason Moore et al.   CLINICAL TRANSPLANTATION

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

(2010) M. Wolf   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients

(2008) Glen T. Schumock et al.   CURRENT MEDICAL RESEARCH AND OPINION